P2X7 receptors are a potential novel target for anti-glioma therapies

about

Interleukin-1β has trophic effects in microglia and its release is mediated by P2X7R pore.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.Sustained activation of P2X7 induces MMP-2-evoked cleavage and functional purinoceptor inhibition.

P2860

Q27303076-1D75AF1D-B6F2-41AA-B7B9-68ED8AFD5E5C Q47571865-1DF6586C-BF23-4809-B9CD-9B46589FA324 Q49385617-FD61DAF8-F949-4D7A-B647-4E1EAE2FEF53

P2860

P2X7 receptors are a potential novel target for anti-glioma therapies

Item

http://www.wikidata.org/entity/Q59321165

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2014

@uk

name

P2X7 receptors are a potential novel target for anti-glioma therapies

@en

P2X7 receptors are a potential novel target for anti-glioma therapies

@nl

type

Item

label

P2X7 receptors are a potential novel target for anti-glioma therapies

@en

P2X7 receptors are a potential novel target for anti-glioma therapies

@nl

prefLabel

P2X7 receptors are a potential novel target for anti-glioma therapies

@en

P2X7 receptors are a potential novel target for anti-glioma therapies

@nl

P1476

P2X7 receptors are a potential novel target for anti-glioma therapies

@en

P2093

Christopher A Reid

http://www.w3.org/2001/XMLSchema#string

David A Williams

http://www.w3.org/2001/XMLSchema#string

Kate J Drummond

http://www.w3.org/2001/XMLSchema#string

Mastura Monif

http://www.w3.org/2001/XMLSchema#string

Simon V Liubinas

http://www.w3.org/2001/XMLSchema#string

Terence J O’Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study

The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)

P2X7 receptor expression after ischemia in the cerebral cortex of rats.

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.

Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway.

Microglia in brain tumors.

Microglia: proliferation and activation driven by the P2X7 receptor.

P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.

P2888

s12950-014-0025-4

P31

scholarly article

P356

10.1186/S12950-014-0025-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046479414

http://www.w3.org/2001/XMLSchema#string

P2X7 receptors are a potential novel target for anti-glioma therapies

about

P2860

P2860

P2X7 receptors are a potential novel target for anti-glioma therapies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P433

P478

P577

P6179

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P433

P478

P577

P6179